Switch to ziprazidone treatment is associated with changes in MMN amplitude: a case report.
Salazar
J
J
Ordoño
F
F
Soriano
S
S
Rueda
M
M
Ojeda
E
E
Cozar
R
R
Belloch
V
V
D000161:Acoustic Stimulation / Q000379:methods; D000293:Adolescent; D014150:Antipsychotic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003265:Contingent Negative Variation / Q000187:drug effects* / Q000502:physiology; D004569:Electroencephalography; D006801:Humans; D008297:Male; D009483:Neuropsychological Tests; D010879:Piperazines / Q000494:pharmacology* / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012563:Schizophrenia, Paranoid / Q000188:drug therapy / Q000503:physiopathology*; D013844:Thiazoles / Q000494:pharmacology* / Q000627:therapeutic use
D014150:Antipsychotic Agents; D010879:Piperazines; D013844:Thiazoles; C092292:ziprasidone